From the Vault: Expert Recommendations on Microbiome Balance, Secondary Infections, and Therapeutic Gaps
Managing atopic dermatitis (AD) involves navigating a complex interplay between skin barrier dysfunction and microbial dysbiosis. As clinicians well know, decreased microbial diversity frequently correlates with an increased burden of Staphylococcus aureus, driving severe flares, secondary infections, and complicating routine therapeutic management.
From the JDD Vault, we are highlighting an article titled A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment that outlines clinical guidance from an expert panel of pediatric dermatologists. Utilizing a modified Delphi process, the panel established five core consensus statements addressing the challenges of secondary bacterial infections, antibiotic stewardship, and the critical importance of recognizing S. aureus involvement in everyday practice.
Crucially, the panel underscored a significant, ongoing unmet need in contemporary dermatology: a single, versatile topical therapy capable of effectively addressing inflammation, pruritus, and S. aureus colonization simultaneously across varying disease severities.
Read the full article to review the complete consensus statements and their implications for optimizing patient care.
Blog write-up assisted by AI
